Trends in Molecular Medicine
ReviewMiR-210 – micromanager of the hypoxia pathway
Section snippets
Introduction of hypoxia and microRNA
MiRNAs are a class of single-stranded noncoding RNAs 21–22 nucleotides in length. Genes encoding miRNAs are initially transcribed as part of much longer primary transcripts (pri-miRNAs) [1]. In the nucleus, these primary transcripts are first processed by the type III RNA endonuclease Drosha into pre-miRNAs that are 60–70 nucleotides in length and form a stem–loop structure [2]. The subsequent transport of pre-miRNAs into the cytoplasm by exportin-5 results in further processing by another type
Regulation of miR-210 expression by hypoxia
The hypoxic regulation of miR-210 was first identified by miRNA microarray in 2007 [18]. The stem–loop of miR-210 is located in an intron of a noncoding RNA, which is transcribed from AK123483 on chromosome 11p15.5. The boundary and length of human pri-miR-210 is predicted with high confidence based on expressed sequence tags, gene expression analysis using the captured 5′ 7-methylguanosine cap of mRNA, the location of the transcription start site (TSS), CpG islands and polyadenylation site [19]
Angiogenesis
Virtually all solid tumors contain hypoxic regions that stimulate angiogenesis to sustain tumor growth. One of the major regulators of tumor angiogenesis is vascular endothelial growth factor (VEGF), a gene regulated by hypoxia [26]. Although the increased expression of VEGF promotes angiogenesis, miR-210 might also be involved [25]. MiR-210 targets the receptor tyrosine kinase ligand Ephrin-A3 (EFNA3) (which is one of the most consistently reported miR-210 target genes 17, 25, 27, 28),
MiR-210 in cancer
MiR-210 is frequently elevated in cancer, including glioblastoma [59], melanoma 20, 60, clear cell renal cell carcinoma [61] and lung 62, 63, 64, 65, 66, pancreatic [28] and breast cancer 21, 29, 65, which is consistent with miR-210 promoting cell cycle progression [20]. However, because miR-210 is the most robustly induced miRNA under hypoxia [17], it is possible that elevated miR-210 expression only reflects the in vivo status of tumor hypoxia. Even under nonmalignant physiological conditions
Future challenges
Although much progress has been made since the first report of hypoxic regulation of miRNA three years ago [18], tremendous challenges still lie ahead (Box 1). One challenge common to the entire miRNA research field is the accurate identification of miRNA targets, because ultimately miRNA exerts its biological function by regulating cellular protein levels. The computational prediction of miRNA targets is based on the complementarity of target gene 3′ UTR sequence to the “seed region” sequence
Acknowledgements
This work is supported by NIH grants P01-CA67166 (QTL, AJG) and R01-CA118582 (QTL) and funding from Magee-Womens Research Institute (XH).
Glossary
- Locked nucleic acid (LNA)
- LNA is a modified nucleotide with an extra bridge connecting the 2’ oxygen and 4’ carbon on the ribose moiety. The locked ribose confirmation significantly increases the thermal stability of oligonucleotides where LNA is incorporated. Because of the short target sequence (∼22 nucleotides) of mature miRNA, the LNA nucleotide is usually incorporated into the antisense RNA oligonucleotide for efficient miRNA knockdown.
- MiRNA sponge
- a competitive miRNA inhibitor composed of
References (80)
Human RISC couples microRNA biogenesis and posttranscriptional gene silencing
Cell
(2005)MicroRNAs: target recognition and regulatory functions
Cell
(2009)The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Cell
(1993)Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans
Cell
(1993)- et al.
MicroRNAs and cancer: short RNAs go a long way
Cell
(2009) - et al.
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway
Molecular Cell
(2008) Hypoxia-inducible miR-210 regulates normoxic gene expression involved in tumor initiation
Molecular Cell
(2009)MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand ephrin-A3
J. Biol. Chem.
(2008)An integrated approach for experimental target identification of hypoxia-induced miR-210
J. Biol. Chem.
(2009)- et al.
Hypoxia-inducible factors, stem cells, and cancer
Cell
(2007)
Hypoxia enhances the generation of induced pluripotent stem cells
Cell Stem Cell
miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b
FEBS Letters
Myc requires distinct E2F activities to induce S phase and apoptosis
Mol. Cell
HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation
Cancer Cell
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Cell
HIF-1a induces genetic instability by transcriptionally downregulating mutsa expression
Mol. Cell
MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2
Cell Metab.
Functions of mitochondrial ISCU and cytosolic ISCU in mammalian iron-sulfur cluster biogenesis and iron homeostasis
Cell Metab.
Identification of a microRNA panel for clear-cell kidney cancer
Urology
Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation
Eur. J. Cancer
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
Cancer Cell
Circulating miR-210 is a novel hypoxia marker in pancreatic cancer
Transl. Oncol.
Pancreatic tumors show high levels of hypoxia
Int. J. Radiation Oncology Biol. Phys.
The role of hypoxia in development of the mammalian embryo
Dev. Cell
MicroRNA maturation: stepwise processing and subcellular localization
EMBO J.
The nuclear RNase III Drosha initiates microRNA processing
Nature
MicroRNA biogenesis: coordinated cropping and dicing
Nat. Rev. Mol. Cell Biol.
The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans
Nature
Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA
Nature
MicroRNA functions
Annu. Rev. Cell Dev. Biol.
Identification of hypoxia-inducible factor-1a as a novel target for miR-17-92 microRNA Cluster
Cancer Res.
Downregulation of miR-199a derepresses hypoxia-inducible factor-1a and sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes
Circ. Res.
Regulation of HIF-1a and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration
PLoS ONE
MicroRNA regulation of DNA repair gene expression in hypoxic stress
Cancer Res.
A microRNA signature of hypoxia
Mol. Cell Biol.
Genomic analysis of human microRNA transcripts
Proc. Natl. Acad. Sci. U. S. A.
MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT
Cell Cycle
hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer
Clin. Cancer Res.
Regulation of the histone demethylase JMJD1A by hypoxia-inducible factor 1{alpha} enhances hypoxic gene expression and tumor growth
Mol. Cell Biol.
Cited by (315)
Regulation of cancer stemness, cell signaling, reactive oxygen species, and microRNAs in cancer stem cells
2023, Cancer Stem Cells and Signaling PathwaysMicroRNAs With Mega Functions in Cardiac Remodeling and Repair: The Micromanagement of Matters of the Heart
2023, MicroRNA in Regenerative Medicine, Second EditionA review on the role of miR-210 in human disorders
2023, Pathology Research and PracticeTissue origin of circulating microRNAs and their response to nutritional and environmental stress in rainbow trout (Oncorhynchus mykiss)
2022, Science of the Total EnvironmentThe mechanism of action of non-coding RNAs in placental disorders
2022, Biomedicine and PharmacotherapyCD204-positive M2-like tumor-associated macrophages increase migration of gastric cancer cells by upregulating miR-210 to reduce NTN4 expression
2024, Cancer Immunology, Immunotherapy